AI-generated summary
In a study of D-galactose-treated aging mice, the authors report that transcranial laser therapy at 660 and 810 nm and 8 J/cm2 was associated with better spatial and episodic-like memory and improved brain mitochondrial and apoptosis markers. The lower fluence of 4 J/cm2 had little effect. These are animal results, and the abstract does not report human outcomes.
- Who or what was studied
- Mice in a D-galactose-induced aging model
- Wavelengths
- 660, 810 nm
- Limits stated in the abstract
- The study is in mice, and the abstract does not report human outcomes or a participant count.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm
- Energy density (fluence)
- 8 J/cm2, 4 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Laser, Near-infrared, Mitochondria, Reactive oxygen species, Adenosine triphosphate, Cytochrome c oxidase. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.